IL-6 has been shown to be implicated in diseases associated with bone loss, such as postmenopausal osteoporosis12, rheumatoid arthritis (RA), Paget’s disease13, and multiple myeloma14, in which enhanced IL-6 levels occur. The gene discussed is IL6; the disease is rheumatoid arthritis.